• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环糊精对抗真菌口服唑类药物药理学的影响。

Effect of cyclodextrin on the pharmacology of antifungal oral azoles.

作者信息

Hostetler J S, Hanson L H, Stevens D A

机构信息

Department of Medicine, Santa Clara Valley Medical Center, San Jose, California.

出版信息

Antimicrob Agents Chemother. 1992 Feb;36(2):477-80. doi: 10.1128/AAC.36.2.477.

DOI:10.1128/AAC.36.2.477
PMID:1605615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC188462/
Abstract

Concentrations of oral azoles in serum were compared in a single-dose pharmacologic study in mice. When hydroxypropyl-beta-cyclodextrin was used as a carrier and compared with a standard carrier, polyethylene glycol, drug concentrations determined by bioassay showed that the peak concentration and area under the concentration-time curve were greatly enhanced for itraconazole and saperconazole; moderately enhanced for ketoconazole; but negligibly affected for fluconazole, miconazole, and SCH 42427.

摘要

在一项针对小鼠的单剂量药理学研究中,对血清中口服唑类药物的浓度进行了比较。当使用羟丙基-β-环糊精作为载体并与标准载体聚乙二醇进行比较时,通过生物测定法测定的药物浓度显示,伊曲康唑和沙康唑的峰值浓度和浓度-时间曲线下面积大幅提高;酮康唑适度提高;但氟康唑、咪康唑和SCH 42427受影响可忽略不计。

相似文献

1
Effect of cyclodextrin on the pharmacology of antifungal oral azoles.环糊精对抗真菌口服唑类药物药理学的影响。
Antimicrob Agents Chemother. 1992 Feb;36(2):477-80. doi: 10.1128/AAC.36.2.477.
2
Effect of hydroxypropyl-beta-cyclodextrin on efficacy of oral itraconazole in disseminated murine cryptococcosis.羟丙基-β-环糊精对口服伊曲康唑治疗播散性小鼠隐球菌病疗效的影响
J Antimicrob Chemother. 1993 Sep;32(3):459-63. doi: 10.1093/jac/32.3.459.
3
Influence of grapefruit juice on the systemic availability of itraconazole oral solution in healthy adult volunteers.葡萄柚汁对健康成年志愿者口服伊曲康唑溶液全身可用性的影响。
Pharmacotherapy. 2004 Apr;24(4):460-7. doi: 10.1592/phco.24.5.460.33350.
4
In vitro comparison of the antimycotic activity of a miconazole-HP-beta-cyclodextrin solution with a miconazole surfactant solution.咪康唑 - HP - β - 环糊精溶液与咪康唑表面活性剂溶液抗真菌活性的体外比较
J Antimicrob Chemother. 2001 Jul;48(1):83-7. doi: 10.1093/jac/48.1.83.
5
Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity--drug supersaturation, toxicity on TR146 cells and release from a delivery system.旨在作用于口腔的抗真菌药物的环糊精包合物——药物过饱和、对TR146细胞的毒性以及从给药系统中的释放
Eur J Pharm Biopharm. 1999 Nov;48(3):217-24. doi: 10.1016/s0939-6411(99)00043-0.
6
Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution.伊曲康唑/2-羟丙基-β-环糊精包合物在丙二醇水溶液中的特性研究
Int J Pharm. 1999 Mar 15;179(2):237-45. doi: 10.1016/s0378-5173(98)00393-7.
7
Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection.人类免疫缺陷病毒感染患者静脉注射伊曲康唑后再服用伊曲康唑口服溶液的药代动力学
J Clin Pharmacol. 2001 Dec;41(12):1319-28. doi: 10.1177/00912700122012904.
8
Improvement of ursodeoxycholic acid bioavailability by 2-hydroxypropyl-beta-cyclodextrin complexation in healthy volunteers.
Pharmacol Res. 1995 Mar-Apr;31(3-4):205-9. doi: 10.1016/1043-6618(95)80019-0.
9
Beta-cyclodextrins enhance bioavailability of pilocarpine.β-环糊精可提高毛果芸香碱的生物利用度。
Curr Eye Res. 1993 Jul;12(7):641-7. doi: 10.3109/02713689309001843.
10
Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.注射用羟丙基环糊精。II:对兔和人体脂质转运与处置的影响。
J Pharm Sci. 1992 Jun;81(6):524-8. doi: 10.1002/jps.2600810610.

引用本文的文献

1
Systemic Antifungal Therapy for Invasive Pulmonary Infections.侵袭性肺部感染的全身性抗真菌治疗
J Fungi (Basel). 2023 Jan 21;9(2):144. doi: 10.3390/jof9020144.
2
Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.用于治疗烟曲霉的缓释伊曲康唑无定形固体分散体:动物模型选择的重要性
Drug Dev Ind Pharm. 2017 Feb;43(2):264-274. doi: 10.1080/03639045.2016.1236811. Epub 2016 Oct 5.
3
Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity.载咪康唑固体脂质纳米粒:一种具有高生物利用度和抗真菌活性的新型配方的制备与评价
Int J Nanomedicine. 2016 Jan 25;11:441-7. doi: 10.2147/IJN.S100625. eCollection 2016.
4
Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth.伊曲康唑,一种常用的抗真菌药物,可抑制 Hedgehog 通路活性和肿瘤生长。
Cancer Cell. 2010 Apr 13;17(4):388-99. doi: 10.1016/j.ccr.2010.02.027.
5
Role of posaconazole in the management of oropharyngeal and esophageal candidiasis.泊沙康唑在口咽和食管念珠菌病治疗中的作用。
Ther Clin Risk Manag. 2007 Aug;3(4):533-42.
6
Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis.伊曲康唑与氟康唑在球孢子菌性脑膜炎小鼠模型中的治疗比较。
Antimicrob Agents Chemother. 2007 Mar;51(3):998-1003. doi: 10.1128/AAC.00332-06. Epub 2006 Dec 18.
7
Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs.建立一种伴有播散至内脏器官的口腔胃肠道念珠菌病黏膜模型。
Antimicrob Agents Chemother. 2006 Aug;50(8):2650-7. doi: 10.1128/AAC.00530-06.
8
Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing.超临界二氧化碳处理制备的咪康唑/羟丙基-γ-环糊精/L-酒石酸包合物在猪体内的口服生物利用度。
AAPS J. 2005 Aug 18;7(1):E149-55. doi: 10.1208/aapsj070116.
9
Efficacy of posaconazole in a murine model of central nervous system aspergillosis.泊沙康唑在中枢神经系统曲霉病小鼠模型中的疗效。
Antimicrob Agents Chemother. 2004 Oct;48(10):4063-6. doi: 10.1128/AAC.48.10.4063-4066.2004.
10
Efficacy of micafungin alone or in combination against systemic murine aspergillosis.米卡芬净单独使用或联合使用对系统性小鼠曲霉病的疗效。
Antimicrob Agents Chemother. 2003 Apr;47(4):1452-5. doi: 10.1128/AAC.47.4.1452-1455.2003.

本文引用的文献

1
Disposition of ketoconazole, an oral antifungal, in humans.酮康唑(一种口服抗真菌药)在人体内的处置。
Antimicrob Agents Chemother. 1982 Jan;21(1):151-8. doi: 10.1128/AAC.21.1.151.
2
Cyclodextrins in drug carrier systems.药物载体系统中的环糊精
Crit Rev Ther Drug Carrier Syst. 1987;3(1):1-40.
3
Pharmacology and toxicity of high-dose ketoconazole.高剂量酮康唑的药理学与毒性
Antimicrob Agents Chemother. 1987 Dec;31(12):1874-8. doi: 10.1128/AAC.31.12.1874.
4
The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection.食物对浅表真菌感染患者伊曲康唑药代动力学的影响。
J Am Acad Dermatol. 1987 Aug;17(2 Pt 1):220-3. doi: 10.1016/s0190-9622(87)70194-7.
5
Treatment of paracoccidioidomycosis with itraconazole in a murine model.
J Trop Med Hyg. 1985 Oct;88(5):295-9.
6
Treatment of invasive aspergillosis with itraconazole.伊曲康唑治疗侵袭性曲霉病
Am J Med. 1989 Jun;86(6 Pt 2):791-800. doi: 10.1016/0002-9343(89)90475-0.
7
Increased gastric pH and the bioavailability of fluconazole and ketoconazole.胃内pH值升高以及氟康唑和酮康唑的生物利用度增加。
Ann Intern Med. 1991 May 1;114(9):755-7. doi: 10.7326/0003-4819-114-9-755.
8
Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography.氟康唑生物测定法的标准化以及结果与高压液相色谱法所得结果的相关性。
Antimicrob Agents Chemother. 1991 May;35(5):846-50. doi: 10.1128/AAC.35.5.846.